AFFLUENT MEDICAL SA (AFME.PA) Stock Analyst Ratings
Europe - Euronext Paris - EPA:AFME - FR0013333077 - Common Stock
1.52 EUR
-0.06 (-3.8%)
ChartMill assigns a Buy % Consensus number of 86% to AFME.PA. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 3.72. This target is 144.93% above the current price.
AFME.PA was analyzed by 10 analysts. The buy percentage consensus is at 86. So analysts seem to be very confident about AFME.PA.
In the previous month the buy percentage consensus was at a similar level.
AFME.PA was analyzed by 10 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2023-12-19 | PORTZAMPARC BNP PARIBAS | Maintains | Buy -> Buy |
AFFLUENT MEDICAL SA / AFME.PA FAQ
What is the price target for AFME stock?
10 analysts have analysed AFME.PA and the average price target is 3.72 EUR. This implies a price increase of 144.93% is expected in the next year compared to the current price of 1.52.
How do analysts rate AFFLUENT MEDICAL SA (AFME.PA)?
The consensus rating for AFFLUENT MEDICAL SA (AFME.PA) is 86 / 100 . This indicates that analysts generally have a positive outlook on the stock.
Can you provide the analyst count for AFFLUENT MEDICAL SA stock?
The number of analysts covering AFFLUENT MEDICAL SA (AFME.PA) is 10.